Lilly(Eli) & Company

NYSE: LLY
$921.49
+$6.45 (+0.7%)
Closing Price on September 20, 2024

LLY Articles

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume...
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –...
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down...
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled a...
These are some of the top analyst downgrades and cautious research calls we have seen from Wall Street early this Tuesday morning: Ansys (ANSS) Cut to Neutral from Overweight at JPMorgan. Cabot (CBT)...
According to Reuters, government talk of auto company bankruptcy may cause creditors and the UAW to renew talks with GM (GM) and Chrysler. Reuters reports that Obama is talking a hefty agenda with...
These are te upgrades and positive research calls that we have seen from Wall Street this Wednesday morning: Advance Auto Parts (AAP) Started as Outperform at Baird. AutoZone (AZO) Started as...
According to Reuters, Steve Jobs will take a medical leave from Apple (AAPL) until June 30. Reuters reports that Bank of America (BAC) is in discussions with the government to get billions of extra...
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions.  The FT reported that the world’s largest pharmaceutical company is willing to...
According to Reuters, cities and states are facing shortfalls and potential defaults. Reuters reports that the US steel industry is starting a "buy America" campaign. Reuters reports that Fannie Mae...
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately.  But shares have just now gotten back above the single-digit threshold and are up more than 80% from recent lows. ...
These are some of the top pre-market analyst downgrades we are seeing this Friday morning: Advanced Medical Optics (EYE) Cut to Underperform at Jefferies. Charles River (CRL) Cut to Market Perform at...